PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Short Interest Update

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) was the target of a significant growth in short interest in the month of June. As of June 15th, there was short interest totaling 17,420 shares, a growth of 109.6% from the May 31st total of 8,311 shares. Based on an average daily trading volume, of 260,335 shares, the short-interest ratio is presently 0.1 days.

PharmaTher Price Performance

Shares of PHRRF stock traded down $0.00 on Tuesday, reaching $0.04. 9,990 shares of the company’s stock were exchanged, compared to its average volume of 171,635. The company’s fifty day simple moving average is $0.05 and its 200 day simple moving average is $0.06. PharmaTher has a 52 week low of $0.03 and a 52 week high of $0.55.

PharmaTher Company Profile

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.